Rajal B Shah, MD, Expert Urologic Pathology
Rajal B Shah, MD, Expert Urologic Pathology
  • 40
  • 158 043
BAUP Webinar on Atypical Large Gland Prostatic Proliferations
Atypical large gland proliferation of the prostate comprises some of the challenging and controversial aspects of prostate pathology. In this unique educational format conducted and organized by the British Association of Urological Pathology (BAUP), Dr. Glen Kristiansen and I (Dr. Rajal B Shah) discuss a practical approach to these spectra of prostatic lesions
Переглядів: 1 109

Відео

Inverted (endophytic) Urothelial Lesions
Переглядів 936Рік тому
Inverted or endophytic urothelial lesions is often a diagnostically challenging spectrum in urinary tract specimens. Dr. Priti Lal, an accomplished pathologist with vast experience in the urologic pathology field show us in this video how to approach these lesions.
Amyloidosis of Urinary Tract and Male Genital System
Переглядів 324Рік тому
Accurate diagnosis of amyloid deposits is important but is just the beginning of a potentially perplexing problem. Learn from this video how pathologists play a critical role in the diagnosis and subsequent management of this disorder.
Role of Pathologist in mpMRI-guided Detection of Prostate Cancer
Переглядів 574Рік тому
There has been a paradigm shift in the way prostate cancer is diagnosed and managed. multiparametric MRI is the imaging method of choice in patients suspected of clinically significant prostate cancer. Pathologists need to understand their changing role and integrate this modality for improved diagnosis and management of patients
Enrichment of "cribriform" morphologies and genomic alterations in radiorecurrent prostate cancer
Переглядів 480Рік тому
Listen to my Modern Pathology Podcast/Chat with editor-in-chief Dr. George Netto featuring our recent publication: Enrichment of "cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer
Radiorecurrent Prostate Cancer - Modern Pathology
Переглядів 405Рік тому
Locally recurrent prostate cancer following radiation therapy is associated with significant morbidity and mortality. In this study, published in Modern Pathology we try to investigate morphological and molecular characteristics that might contribute to therapy resistance and failure
Histological Criteria for Diagnosis of Prostate Cancer - A Complete Guide
Переглядів 2,3 тис.2 роки тому
This is the entire presentation as taught to my residents at UT Southwestern Medical Center, Dallas, Texas
Contemporary Gleason Grading of Prostate Cancer - Complete Guide
Переглядів 3,4 тис.2 роки тому
This is the complete presentation that I taught to my residents at UT Southwestern Medical Center, Dallas, Texas
A Dummies Guide to Recognizing Treatment Effects in Prostate Cancer
Переглядів 8372 роки тому
Recognizing treatment effects in prostate cancer is important for several reasons: avoiding over diagnosis, avoiding over grading, and in certain settings for determination of appropriate salvage treatment options. Learn from this simplified video how to recognize various treatment effects in prostate cancer
A Dummies Guide to Adrenal Mass Evaluation
Переглядів 4,8 тис.2 роки тому
Adrenal specimens are an infrequent but often challenging spectrum of tumors where the determination of malignant potential could be especially a challenge. This simplified diagnostic approach outlines comprehensive yet easy-to-follow guidelines.
Spermatocytic tumor of testis - A great mimicker of Seminoma
Переглядів 1,3 тис.2 роки тому
Spermatocytic tumor of testis - A great mimicker of Seminoma
Reproducible Morphological Features For Diagnosis of Cribriform Prostate Adenocarcinoma
Переглядів 9902 роки тому
There is growing evidence that cribriform morphology in prostate cancer impacts clinical decision-making in prostate cancer management. Using any morphological features that impact clinical decision-making requires that particular feature should be highly reproducible among pathologists. Learn to apply reproducible morphological features for this diagnosis from our interobserver reproducibility...
Diagnostic Approach to Cribriform Lesions of Prostate - PathPresenter Masterclass in Pathology 2021
Переглядів 2,3 тис.2 роки тому
Enjoy the full virtual microscopy-based presentation of the Diagnostic approach to cribriform lesions of the prostate gland as taught in PathPresenter Masterclass in Pathology 2021
Learn How to Take Advantage of New High-yield Digital Slide Educational Resource
Переглядів 4642 роки тому
Attention trainees: Genitourinary Pathology Society (GUPS) in partnership with PathPresenter, a virtual microscopic educational platform have partnered to develop high-yield urologic pathology digital slide collection. These slides are annotated simulating learning over a multiheaded microscope with an expert! In this video, Dr. Raj Singh and I discuss the platform and show you how you can take...
How To Build A Successful Career In Pathology - My Career Lessons
Переглядів 1,3 тис.3 роки тому
Pathology specialty is entering in what I call Pathology, version 2. It is important for every pathology trainee and medical student who aspire to become a pathologist to understand the opportunities, trends, disruptors, and challenges that surround this specialty. Watch this video in which I provide you tips on how you can build a successful career in pathology from my career lessons!
A Dummies Guide to Pink Cell (Oncocytic) Renal Tumors
Переглядів 6 тис.3 роки тому
A Dummies Guide to Pink Cell (Oncocytic) Renal Tumors
The Paris System for reporting Urinary Cytology
Переглядів 6 тис.3 роки тому
The Paris System for reporting Urinary Cytology
"Atypical glands suspicious for Prostate Adenocarcinoma (ATYP)" in Prostate biopsy
Переглядів 2,9 тис.3 роки тому
"Atypical glands suspicious for Prostate Adenocarcinoma (ATYP)" in Prostate biopsy
A Dummies Guide to Pathologic Staging of Prostate Cancer (Radical Prostatectomy Specimen)
Переглядів 6 тис.3 роки тому
A Dummies Guide to Pathologic Staging of Prostate Cancer (Radical Prostatectomy Specimen)
Tubulocystic Renal Cell Carcinoma
Переглядів 1,8 тис.3 роки тому
Tubulocystic Renal Cell Carcinoma
MiT Family Translocation Renal Cell Carcinoma
Переглядів 2,4 тис.3 роки тому
MiT Family Translocation Renal Cell Carcinoma
Prostate Cancer with "Cribriform Architecture"
Переглядів 3,7 тис.3 роки тому
Prostate Cancer with "Cribriform Architecture"
Neuroendocrine prostate cancer
Переглядів 1,9 тис.3 роки тому
Neuroendocrine prostate cancer
High-grade prostatic intraepithelial neoplasia (HGPIN)
Переглядів 5 тис.4 роки тому
High-grade prostatic intraepithelial neoplasia (HGPIN)
Ductal adenocarcinoma of the prostate
Переглядів 4,3 тис.4 роки тому
Ductal adenocarcinoma of the prostate
A Dummies Guide to Benign Mimics of Prostate Cancer: Part 3 Mimics of High grade cancer
Переглядів 1,5 тис.4 роки тому
A Dummies Guide to Benign Mimics of Prostate Cancer: Part 3 Mimics of High grade cancer
A Dummies Guide to Benign Mimics of Prostate Cancer: Part 2. Small Glandular Mimics
Переглядів 2,6 тис.4 роки тому
A Dummies Guide to Benign Mimics of Prostate Cancer: Part 2. Small Glandular Mimics
Introduction and Welcome to My Channel: Expert Urologic Pathology
Переглядів 2,9 тис.4 роки тому
Introduction and Welcome to My Channel: Expert Urologic Pathology
A Dummies Guide to Testicular Germ Cell Tumors
Переглядів 16 тис.4 роки тому
A Dummies Guide to Testicular Germ Cell Tumors
A Dummies Guide to Bladder Cancer Diagnosis
Переглядів 17 тис.4 роки тому
A Dummies Guide to Bladder Cancer Diagnosis

КОМЕНТАРІ

  • @annaj7058
    @annaj7058 9 днів тому

    Hi Dr Shah - I'm an Anatomical Path Registrar in my first year of training and I just wanted to thank you for your excellent lectures - they have helped me develop my knowledge of genitourinary pathology so much. You are an incredibly gifted teacher.

  • @raghumenon9966
    @raghumenon9966 27 днів тому

    Very good presentation, clearly explaining all key points

  • @akanksham1920
    @akanksham1920 Місяць тому

    Thank you sir for the excellent presentation. Can low grade urothelial carcinomas be lamina propria invasive ? Should one be very cautious signing this out as its rare?

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath Місяць тому

      That is a great question! In my opinion, low-grade and invasion are oxymoron. I have virtually never signed out invasive low-grade urothelial carcinoma. there are case series, though suggesting such association. Regardless, once the urothelial carcinoma is invades, the grade does not matter.

  • @user-cj7dj4hn2k
    @user-cj7dj4hn2k 2 місяці тому

    Excellent slide presentation Dr. Shah. Is it still true today that the predictive value of HGPIN has declined significantly now 6 years after this video?

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath Місяць тому

      Yes, the predictive value of HGPIN has significantly declined in recent years. The Video is not six years old though!

  • @Dee-bomb
    @Dee-bomb 2 місяці тому

    Thank you for great lecture! Unfortunately cannot see the complete tables bc of your lecture box in the lower right corner😭

  • @raghunathram545
    @raghunathram545 2 місяці тому

    This series has to continue and increase in frequency. Very helpful!

  • @henryweatherly8865
    @henryweatherly8865 3 місяці тому

    i would nominate you for the nobel prize if i could. Wonderful presentation!

  • @salbers
    @salbers 3 місяці тому

    I feel this talk is incorrectly titled as for "...dummies" which is misleading. I suggest it be changed to incorporate the characterization that it is for inquiring minds.

  • @pnaratasoy1724
    @pnaratasoy1724 3 місяці тому

    Thank you very much

  • @gordonchristophertubo3164
    @gordonchristophertubo3164 4 місяці тому

    Everytime the picture changes, I get a jump scare because of the sudden spike in your voice volume! XD Nontheless a very informative lecture doctor, thank you very much!

  • @josegomez-garcia6978
    @josegomez-garcia6978 4 місяці тому

    excellent. thanks Dr. Shah.

  • @latham4538
    @latham4538 4 місяці тому

    Hello sir may I know how many percentage of clear cell carcinoma can express AMACR

  • @amassry2276
    @amassry2276 4 місяці тому

    Thank you very much for this fantastic and illustrative lecture ❤

  • @pindiwal7
    @pindiwal7 4 місяці тому

    Great explanation of some of the confusing concepts of the updated Gleason grading. Thank you Dr. Shah.

  • @pindiwal7
    @pindiwal7 4 місяці тому

    Excellent lecture with very practical teaching points. Thank you Dr. Shah.

  • @sairaahsan8148
    @sairaahsan8148 5 місяців тому

    Excellent lecture ! Thanks sir

  • @raghunathram545
    @raghunathram545 5 місяців тому

    Excellent! It can't be made more succinct. Hope more of these are made available.

  • @jeffrunning713
    @jeffrunning713 6 місяців тому

    I have been diagnosed with intraductal carcinoma and researching this form of prostate cancer. Thank you for your instruction.

  • @paulgrab3
    @paulgrab3 6 місяців тому

    Thank you very much for the excellent lecture.

  • @vincentgraffeo4182
    @vincentgraffeo4182 6 місяців тому

    Fantastic presentation!

  • @MirunaPopescuMD
    @MirunaPopescuMD 7 місяців тому

    Fantastic presentation! Please keep this format going, it's a valuable contribution to GU pathology education!!

  • @user-os5xj7ce4k
    @user-os5xj7ce4k 8 місяців тому

    My husband has Gleason 7 3+4 Criboform 4. One surgeon wanted to take it out, and another wants to radiate. With criboform in your opinion what is the best way

  • @surbhirajauria9859
    @surbhirajauria9859 8 місяців тому

    what is the name of your book sir

  • @SandhyaRamachandran
    @SandhyaRamachandran 9 місяців тому

    Thank you ! What would the IHC be in a Hybrid Oncocytic Tumour please..?

  • @quikcyto4094
    @quikcyto4094 9 місяців тому

    please keep the interactive and free discussion format

  • @quikcyto4094
    @quikcyto4094 9 місяців тому

    loved the interactive format.

  • @naegleriafowleri2230
    @naegleriafowleri2230 10 місяців тому

    What about chronic prostatitis it can mimic cancer too how common is it?

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath 10 місяців тому

      If the cellular infiltrate of the chronic prostatitis is extensive and poorly preserved, it may mimic as a high-grade tumor. Importantly, when cellular infiltrate is concentrated around the ducts and glands, it likely represents a benign process.

  • @YB-lv6ks
    @YB-lv6ks 10 місяців тому

    Great presentation! Should we perform FH immunostaining even if it shows 100% tubulocystic morphology?

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath 10 місяців тому

      Great question. You may skip if 100% morphology fits with TCC. However, overall a low threshold is recommended for FH staining

    • @YB-lv6ks
      @YB-lv6ks 10 місяців тому

      Thank you, Dr. Rajal. May I ask another question? When to suspect ALK- rearranged RCC?

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath 10 місяців тому

      @@YB-lv6ks there is very limited data on this rare entity. Overall, I do use ALK-1 whenever I have a high-grade tumor that does not fit into any of the known types. I have yet to encounter a real case. It is very rare entity.

  • @seoyoungpark9253
    @seoyoungpark9253 10 місяців тому

    Thank you for your effort This was so informative!

  • @seoyoungpark9253
    @seoyoungpark9253 10 місяців тому

    This lecture is more helpful than any other resources Thank you so much sir!

  • @salmaafzal5178
    @salmaafzal5178 10 місяців тому

    Wonderful presentation sir, thanks for clearing the concept

  • @soumyamajumdar7929
    @soumyamajumdar7929 11 місяців тому

    need a diagram for cell spaces of the urinary bladder?

  • @SimpliMedic
    @SimpliMedic 11 місяців тому

    Explained in a nice and simple way. Very helpful lecture. Thank you sir.

  • @RP-iq9gb
    @RP-iq9gb 11 місяців тому

    What is the best treatment for metastatic Tubulocystic RCC? Thank you!

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath 11 місяців тому

      Good question. There is no specific targeted therapy for Tubulocystic RCC. Surgery is the best option

  • @abm2497
    @abm2497 Рік тому

    JAJAJAJAJAJJAJAJAJ el título

  • @lamwlw
    @lamwlw Рік тому

    Transcript: " We will discuss the diagnostic criteria in each category in detail. First, we will discuss adequacy in urinary cytology. The following conditions meet the criteria for “Unsatisfactory for Evaluation”: •Acellular or virtually acellular sample •Less than 10 urothelial cells for a voided urine or less than 15 cells for an instrumented urine •Presence of only keratinizing squamous cells •Specimen contains >75% obscuring debris, inflammation, or lubricant •Presence of any atypical or malignant cells is adequate for evaluation. •For voided urine: >30 ml, contains any urothelial cells; for instrumented urine: ≥2 urothelial cells/HPF or ≥200 cells. NHGUC: negative for high-grade urothelial carcinoma. This includes a variety of situations that previously could be in the “Atypical” category. It includes benign urothelial, glandular, and squamous cells; fragments; clusters; changes with urolithiasis; viral cytopathic effect; post-therapy effects; diversion urine, etc. It is important to know this category well, as some are close mimickers of atypical urothelial cells. We will discuss this category in detail. Umbrella cells can be mono-, bi-, or multi-nucleated. Cytoplasm is dense or vacuolated. Cell membrane is sharply demarcated, generally with one flat edge. Multi-nucleation is called “endomitosis” and is caused by nuclear division without cytoplasmic division. Some umbrella cells can be smaller with degenerated (pyknotic) nuclei and mimic atypical cells. Glandular cells can be columnar or cuboidal, generally seen in instrumented urine. They may be derived from cystitis cystica or glandularis or the female genital tract. Renal tubular cells are small, generally poorly preserved with pyknotic, dark, eccentric nuclei and granular cytoplasm. They are easier to recognize when they form small clusters or casts. Seminal vesicle cells have enlarged, hyperchromatic nuclei. High N/C ratio can also have prominent nucleoli, mimicking high-grade urothelial cells. Presence of yellow-brown cytoplasmic lipofuscin pigment and sperm in the urine specimen are important clues for identification. They can also cause abnormal DNA ploidy measurement. Intermediate and basal cells often discriminate in clusters with stones, infection, or procedures. Cell clusters with urolithiasis can be 2-3D, spherical, with smooth cytoplasmic contours. Intermediate cell clusters may have a feathery appearance at the periphery. These clusters can be abundant in instrumented urine but can also be present in voided urine. When the clusters show no obvious cytological atypia and no fibrovascular core, they are considered “pseudo-papillae” and should be classified as NHGUC, but a comment could be added that LGUN cannot be ruled out without clinical correlation, as urine cytology has low sensitivity for detecting LGUN. Polyomavirus: The typical findings have been described as “decoy cells,” “comet cells,” or “net cells” with large homogeneous opaque or ground glass intranuclear inclusions. However, in different stages of infection, the cytopathological features may not be typical. When viral particles leach out, chromatin may be coarse, mimicking HGUC; atypical diagnosis may be rendered. BCG, mitomycin, and thiotepa may be intravesically administered. They cause inflammatory response, producing sloughing and degeneration of both benign and neoplastic urothelium. Mitomycin and thiotepa can cause nuclear enlargement, hyperchromasia, smudgy chromatin, and degenerated or vacuolated cytoplasm. Most have a low N/C ratio. When they have a high N/C ratio, they closely mimic HGUC. Systemically administered drugs like cyclophosphamide and busulfan may also cause marked cellular abnormalities. Radiation effects are characterized by cytomegaly with nuclear enlargement, multinucleation, and abundant vacuolated cytoplasm, maintaining a low N/C ratio. Next is AUC: Atypical Urothelial Cells. Diagnostic criteria are: • Non-superficial, non-degenerated cells with increased N/C ratio >0.5 • Plus one of the following nuclear features: › Nuclear hyperchromasia, OR › Irregular, clumpy chromatin, OR › Irregular nuclear membrane, OR More pictures of AUC. They also have increased N/C ratio. Some clusters show irregular nuclear membrane. Some show nuclear hyperchromasia. Some show irregular, clumpy chromatin. Next is HGUC: High-Grade Urothelial Carcinoma. Diagnostic criteria include: • N/C ratio >0.7 • Moderate to severe nuclear hyperchromasia • Irregular nuclear membrane • Coarse, clumped chromatin • Quantity also matters here; needs at least 5-10 abnormal cells for HGUC. Other notable cytomorphological features include cellular pleomorphism, prominent nucleoli, mitoses, necrosis, etc. Urinary cytology has high sensitivity and specificity in detecting both high-grade papillary urothelial carcinoma and CIS. Next is SHGUC: Suspicious for High-Grade Urothelial Carcinoma. Diagnostic criteria include: • Increased N/C ratio and hyperchromasia • Plus one of the following: › Irregular, clumpy chromatin › Irregular nuclear membranes For N/C ratio, the TPS book uses 0.5-0.7, which is similar to AUC category. However, recent lectures from Dr. Wojcik and Dr. Barkan use N/C ratio >0.7, which is close to HGUC category. I hope TPS 2.0 can better clarify this discrepancy. Quantity matters here. If only <10 abnormal cells meet criteria for HGUC, classify as SHGUC. This is the diagnostic approach used by Dr. Barkan. So AUC is classified as “mild Atypia,” HGUC and SHGUC are classified as “severe atypia” with similar nuclear features but different quantities. N/C ratio is an important diagnostic criterion in TPS. Studies show human eyes are accurate in estimating N/C ratios close to 0.7 but less accurate close to 0.5. The chart is helpful in training your eyes to estimate N/C ratios. Next is LGUN: Low-Grade Urothelial Neoplasm, which includes papilloma, papillary neoplasm, and LG UC. Diagnostic criteria include: • 3D cell clusters with definitive fibrovascular cores. Studies show cell blocks help identify fibrovascular cores, but cell blocks are not routinely done in most practices. • In our practice, LGUN is a very difficult diagnosis without concurrent biopsy or cystoscopic correlation. The last category is “Other Malignancies,” including primary carcinomas (urothelial, squamous, glandular), secondary malignancies (extension from adjacent organs like prostate or RCC), and metastases. A few examples: • Adenocarcinoma: Eccentrically placed irregular nuclei, clumped and hyperchromatic chromatin, finely vacuolated cytoplasm. • Clear cell RCC: “Hobnail” cell configuration, abundant clear/vacuolated cytoplasm, centrally located nucleus, prominent nucleolus. • Lymphoma and melanoma can also be seen. This table illustrates the risk of HGUC and clinical management for each TPS diagnostic category. Specific points: • Management of AUC: This has been a dilemma. AUC used to include a wide spectrum from benign to malignant. Now, under TPS, conditions like reactive, polyoma, urolithiasis, treatment effect are NHGUC. AUC rate is lower in most practices for TPS, and AUC is a more serious diagnosis. • Potential value of ancillary tests like FISH, especially for AUC and SHGUC. In our recent publication in Cancer Cytopathology, Dr. Shan and I studied the impact of implementing TPS at Inform Diagnostics, studying >27,000 cases for 2 years before and after TPS implementation. Our data showed AUC decreased from 29% to 6.2%. Breaking down by specimen: • Voided urine: AUC decreased from 27% to 6% (75% decrease) • Instrumented urine: AUC decreased from 37% to 9% (75% decrease) We also examined UroVysion FISH results and follow-up surgical results when available for different urinary cytology diagnoses. • AUC associated with positive FISH increased from 16.7% to 37.6%. • AUC associated with follow-up HGUC increased from 9% to 57%. This table shows the cytology performance in detecting urothelial carcinoma. The performance of AUC for detecting HGUC was significantly improved (red font). Specificity increased from 49% to 86%. Positive predictive value improved from 9% to 39%. Accuracy improved from 50% to 85%. In conclusion, implementing TPS resulted in a significant decrease in atypical diagnoses and significant improvement in specificity and PPV in detecting HGUC. AUC was significantly better correlated with UroVysion results, decreasing UroVysion test requests and saving medical costs. AUC should be considered a clinically relevant group requiring serious clinical workup in the TPS era. Lastly, urinary cytology has low sensitivity in detecting LGUN. Sensitivity may be even lower in TPS. It is important for urologists to understand the limitations of urinary cytology and implications of changes introduced by TPS to best manage patient care. Thank you."

  • @pavithrayatra
    @pavithrayatra Рік тому

    Hi doctor I have been diagnosed with adrenal adenoma on the left side and I'm on eplenerone. Is there a possibility of getting an AVS done in India?

  • @rattarojwattanasirirux2629

    Outstanding lecture Sir; God bless you and your family

  • @beaubiddle834
    @beaubiddle834 Рік тому

    Outstanding! Thank you!

  • @eduardosanojacastellano9402

    Gracias por estas charlas, siempre las estoy visitando para refrescar la memoria

  • @bahaaibrahim9404
    @bahaaibrahim9404 Рік тому

    Great lecture Dr. Lal! Thank you!!

  • @aniqahshamimi8300
    @aniqahshamimi8300 Рік тому

    Tq❤

  • @annaj7058
    @annaj7058 Рік тому

    This was a simply excellent lecture - thank you so much, you are a gifted teacher Dr Shah!

  • @alenwargis9744
    @alenwargis9744 Рік тому

    Thank you Sir. 🙏🙏

  • @essamahmed9242
    @essamahmed9242 Рік тому

    Thank you Dr Wei Tian for the excellent presentation and thanks to Shah for inviting Dr Wei Tian

  • @essamahmed9242
    @essamahmed9242 Рік тому

    Excellent presentation Thanks for your valuable videos

  • @lastanatomy9
    @lastanatomy9 Рік тому

    Thanks 👍👍👍

  • @DrAppy01
    @DrAppy01 Рік тому

    Sir amazing lecture. If you could also consider making a video on how to screen TURPs and when to suspect a sneaky Prostatic adenoca in TURPs when you have 25 slides to see! 😅

  • @banchidhaba5521
    @banchidhaba5521 Рік тому

    Thankyou doc.I found it very helpful .! From Ethiopia

  • @essamahmed9242
    @essamahmed9242 Рік тому

    Excellent presentation. Thank you for posting. I hope you don’t mind me asking a question. TURBT was done for bladder tumor in 62 year old man and on microscopic examination, there are prominent polyploid projections (no true papillae) with marked acute inflammation and exuberant eosinophils in mucosa, submucosa and muscularis propria (no necrosis in the latter). Is eosinophilic cystitis (EC) the correct diagnosis? EC is rare but we recently encountered 3 cases with similar histology making us question this diagnosis. Thank you very much.

    • @rajalbshahExperturologicpath
      @rajalbshahExperturologicpath Рік тому

      Great and difficult question. There are no well-defined objective criteria for eosinophilic cystitis. The diagnosis depends on both combined histopathology and clinical . the presence of exuberant eosinophils that you describe is likely related to that diagnosis. Overall, I would descriptively mention this finding in report and ask them to correlate clinically. Hope this comment is helpful to you.

    • @essamahmed9242
      @essamahmed9242 Рік тому

      @@rajalbshahExperturologicpath Very helpful. Thank you very much.